EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma

X.D. Li, A. Garant, L. Robles, P. Kapur, C. Ahn, S. Woldu, V. Margulis, J. Cadeddu, R.D. Timmerman, R. Hannan

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S58-S59

DOI: 10.1016/j.ijrobp.2026.06.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von X.D. Li und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, X., Garant, A., Robles, L., Kapur, P., Ahn, C., Woldu, S., Margulis, V., Cadeddu, J., Timmerman, R., & Hannan, R. (2026). Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 126(1), S58-S59. https://doi.org/10.1016/j.ijrobp.2026.06.045

Vancouver

Li X, Garant A, Robles L, Kapur P, Ahn C, Woldu S, et al. Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S58-S59. doi:10.1016/j.ijrobp.2026.06.045

BibTeX
@article{Li2026,
  author = {Li, X.D. and Garant, A. and Robles, L. and Kapur, P. and Ahn, C. and Woldu, S. and Margulis, V. and Cadeddu, J. and Timmerman, R.D. and Hannan, R.},
  title = {Long-Term Outcomes from a Phase 2 Trial of Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S58--S59},
  doi = {10.1016/j.ijrobp.2026.06.045}
}
Kostenlos starten →